Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia-The SPASTOX Trial
- PMID: 34302383
- PMCID: PMC8361968
- DOI: 10.1002/mds.28659
Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia-The SPASTOX Trial
Comment in
-
Reply to: "Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia-The SPASTOX Trial".Mov Disord. 2021 Jul;36(7):1734-1735. doi: 10.1002/mds.28658. Mov Disord. 2021. PMID: 34302384 No abstract available.
Comment on
-
Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia - The SPASTOX Trial.Mov Disord. 2021 Jul;36(7):1654-1663. doi: 10.1002/mds.28523. Epub 2021 Feb 17. Mov Disord. 2021. PMID: 33595142 Clinical Trial.
References
-
- Nonnekes J, Goselink RJM, Ruzicka E, Fasano A, Nutt JG, Bloem BR. Neurological disorders of gait, balance and posture: a sign‐based approach. Nat Rev Neurol 2018;14(3):183–189. - PubMed
-
- Wissel J, Ward AB, Erztgaard P, et al. European consensus table on the use of botulinum toxin type a in adult spasticity. J Rehabil Med 2009;41(1):13–25. - PubMed
-
- van Lith BJH, den Boer J, van de Warrenburg BPC, Weerdesteyn V, Geurts AC. Functional effects of botulinum toxin type a in the hip adductors and subsequent stretching in patients with hereditary spastic paraplegia. J Rehabil Med 2019;51(6):434–441. - PubMed
-
- Schnitzler A, Roche N, Denormandie P, Lautridou C, Parratte B, Genet F. Manual needle placement: accuracy of botulinum toxin a injections. Muscle Nerve 2012;46(4):531–534. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical